Modified Observer's Assessment of Alertness/Sedation Scale every 15 minutes up to 5 hours after intranasal desmedetomidine [clinicaltrials_resource:8e50e3135201ab8347d74969ec962f76]

Modified Observer's Assessment of Alertness/Sedation Scale every 15 minutes up to 5 hours after intranasal desmedetomidine [clinicaltrials_resource:8e50e3135201ab8347d74969ec962f76]

Heart rate, noninvasive blood pressure, respitory rate, pulse oximetry
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:8e50e3135201ab8347d74969ec962f76
Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD [clinicaltrials:NCT02211118]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Modified Observer's Assessment of Alertness/Sedation Scale every 15 minutes up to 5 hours after intranasal desmedetomidine [clinicaltrials_resource:8e50e3135201ab8347d74969ec962f76]

Heart rate, noninvasive blood pressure, respitory rate, pulse oximetry
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:8e50e3135201ab8347d74969ec962f76
Bio2RDF identifier
8e50e3135201ab8347d74969ec962f76
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:8e50e3135201ab8347d74969ec962f76
measure [clinicaltrials_vocabulary:measure]
Modified Observer's Assessment of Alertness/Sedation Scale
time frame [clinicaltrials_vocabulary:time-frame]
every 15 minutes up to 5 hours after intranasal desmedetomidine
description
Heart rate, noninvasive blood pressure, respitory rate, pulse oximetry
identifier
clinicaltrials_resource:8e50e3135201ab8347d74969ec962f76
title
Modified Observer's Assessment ...... ter intranasal desmedetomidine
@en
inDataset
type
label
Modified Observer's Assessment ...... 0e3135201ab8347d74969ec962f76]
@en